COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 1687: Articles 16861-16870  | Next

An In-House ELISA for SARS-CoV-2 RBD uncovers elevatedimmune response at higher altitudes
Tomas Grau, R., Ploper, D., Avila, C. L., Vera Pingitore, E., Maldonado, C., Chaves, S., Socias, S. B., Stagnetto, A., Navarro, S., Chahla, R., Aguilar, M., Llapur, C., Aznar, P., Alcorta, M., Costas, D., Flores, I., Apfelbaum, G., Heinze, D., Mostoslavsky, R., Mostoslavsky, G., Perdigon, G., Cazorla, S., Chehin, R.
10.1101/2021.03.10.21252711 — Posted: 2021-03-12
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers
Padoan, A., Bonfante, F., Cosma, C., Di Chiara, C., Sciacovelli, L., Pagliari, M., Bortolami, A., Costenaro, P., Musso, G., Basso, D., Plebani, M.
10.1101/2021.03.10.21253260 — Posted: 2021-03-12
Global association of obesity and COVID-19 death rates
Adams, M. L.
10.1101/2021.03.09.21253222 — Posted: 2021-03-12
Higher viral load drives infrequent SARS-CoV-2 transmission between asymptomatic residence hall roommates
Bjorkman, K. K., Saldi, T. K., Lasda, E., Conners Bauer, L., Kovarik, J., Gonzales, P. K., Fink, M. R., Tat, K. L., Hager, C. R., Davis, J. C., Ozeroff, C. D., Brisson, G. R., Larremore, D. B., Leinwand, L. A., McQueen, M. B., Parker, R.
10.1101/2021.03.09.21253147 — Posted: 2021-03-12 Discussion: Offsite
The Value of Rapid Antigen Tests to Identify Carriers of Viable SARS-CoV-2.
Shidlovskaya, E. V., Kuznetsova, N. A., Divisenko, E. V., Nikiforova, M. A., Siniavin, A. E., Ogarkova, D. A., Shagaev, A. V., Semashko, M. A., Tkachuk, A. P., Burgasova, O. A., Gushchin, V. A.
10.1101/2021.03.10.21252667 — Posted: 2021-03-12
Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland
Hobbie, S. N.
10.1101/2021.03.10.21253079 — Posted: 2021-03-12
Quantified Flu: an individual-centered approach to gaining sickness-related insights from wearable data
Greshake Tzovaras, B., Senabre Hidalgo, E., Alexiou, K., Baldy, L., Morane, B., Bussod, I., Fribourg, M., Wac, K., Wolf, G., Ball, M.
10.1101/2021.03.10.21252242 — Posted: 2021-03-12
Maximisation of open hospital capacity under shortage of SARS-CoV-2 vaccines
Bosbach, W. A., Heinrich, M., Kolisch, R., Heiss, C.
10.1101/2021.03.08.21253150 — Posted: 2021-03-12
Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents
Haile, S., Nikiforuk, A. M., Pandoh, P. K., Twa, D. D. W., Smailus, D. E., Nguyen, J., Pleasance, S., Wong, A., Zhao, Y., Eisler, D., Moksa, M., Cao, Q., Wong, M., Su, E., Krzywinski, M., Nelson, J. M. T., Mungall, A. J., Tsang, F., Prentice, L. M., Jassem, A., Manges, A. R., Jones, S. J. M., Coope, R. J., Prystajecky, N., Marra, M. A., Krajden, M., Hirst, M.
10.1101/2021.03.09.21251364 — Posted: 2021-03-12
Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice
Silvas, J., Morales Vasquez, D., Park, J.-G., Chiem, K., Torrelles, J., Platt, R. N., Anderson, T., Ye, C., Martinez-Sobrido, L.
10.1101/2021.03.09.434696 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).